Consequently, we propose that YHR may regulate cell autophagy function by interacting with the MAM complex VAPB–PTPIP51 to ameliorate podocyte injury and ultimately achieve therapeutic effects for DN. Here, RMDN3 is linked to liver dysplastic nodule.